Production (Stage)
SRx Health Solutions Inc.
SRXH
$0.588
-$0.0485-7.62%
AMEX
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Revenue | -14.90% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -14.90% | ||||
| Cost of Revenue | -15.17% | ||||
| Gross Profit | -14.36% | ||||
| SG&A Expenses | -34.53% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -24.56% | ||||
| Operating Income | 56.80% | ||||
| Income Before Tax | 68.04% | ||||
| Income Tax Expenses | -6.67% | ||||
| Earnings from Continuing Operations | 68.00% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 68.00% | ||||
| EBIT | 56.80% | ||||
| EBITDA | 57.20% | ||||
| EPS Basic | 90.34% | ||||
| Normalized Basic EPS | 90.00% | ||||
| EPS Diluted | 90.35% | ||||
| Normalized Diluted EPS | 90.00% | ||||
| Average Basic Shares Outstanding | 231.23% | ||||
| Average Diluted Shares Outstanding | 231.23% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||